Abstract:e24088 Background: The American Society of Clinical Oncology (ASCO) recently updated its guidelines on fertility preservation based on similar rates of pregnancy from oocyte and embryo preservation. However, fertility preservation in female pediatric and young adults undergoing cancer treatment remains a challenge due to barriers in communication, lack of awareness and resources. Methods: A survey created using SurveyMonkey was sent electronically to all physicians who were Children’s Oncology Group (COG) members (2190), weekly for 4 weeks. Results: 304 physicians (13.8%) responded to the survey. While most providers discuss the possibility of infertility with all female patients (83%), only 43% offer fertility preservation irrespective of age. Cancer diagnosis is a key factor in the decision to offer fertility preservation to patients (63%). Ewing sarcoma (75%), osteosarcoma (69%), and bone marrow transplant candidacy (70%) are the most common diagnoses associated with physician offering of fertility preservation. It is typically offered prior to the first round of chemotherapy (53%). Seventy-five percent of providers report that insufficient time before starting chemotherapy is a major barrier to offering fertility preservation. Severity of patient illness (58%), insurance issues and high cost (19%), provider belief that it is not necessary in every patient (25%), and lack of data supporting female fertility preservation and experimental methods (16%) are other barriers which impact the decision to offer fertility preservation. Ovarian suppression (77%), cryopreservation (egg freezing) (85%), and ovarian tissue freezing (66%) are the most discussed fertility preservation options with only one out of four providers discussing freezing embryos. Only one out of five providers check Anti-Mullerian hormone (AMH) levels prior to starting cancer treatment; however, two out of five check AMH levels after completion of therapy. Most providers do not check AMH levels. Conclusions: Despite high risk for infertility among female cancer patients due to treatment and several advances that have been made in the field, the practice of offering fertility preservation is not universal due to various barriers at the physician and institutional level. Physician education and familiarity with ASCO’s newer guidelines is one way to promote a healthier dialogue and informed decision making. We also conclude that detailed guidelines and monitoring practices for diminished ovarian reserve are lacking and need further thought.[Table: see text]

A 12-year overview of fertility preservation practice in Nordic pediatric oncology centers

Current Status of Fertility Preservation in Pediatric Oncology Patients

Fertility preservation options in pediatric and adolescent patients with cancer

An approach to fertility preservation in prepubertal and postpubertal females: A critical review of current literature

An update on oncofertility in prepubertal females

Cancer Therapy, Gonadal Function, and Fertility Preservation: Narrative Review

Fertility Preservation in Children and Adolescents during Oncological Treatment—A Review of Healthcare System Factors and Attitudes of Patients and Their Caregivers

Oncofertility care for children, adolescents, and young adults at risk for treatment-related fertility loss

Fertility discussions and concerns in childhood cancer survivors, a systematic review for updated practice

Female Fertility Cryopreservation Outcomes in Childhood Cancer: A Systematic Review

Current Fertility Preservation Steps in Young Women Suffering from Cancer and Future Perspectives

Adolescents and Young Adults With Cancer: Oncology Nurses Report Attitudes and Barriers to Discussing Fertility Preservation

Fertility Preservation in Children and Adolescents: Where We Are and Where We Are Going

Fertility preservation in pediatric solid tumors: A report from the Children's Oncology Group

Current state of fertility preservation for adolescent and young adult patients with gynecological cancer

Barriers to offering female fertility preservation to pediatric and young adult oncology patients: A national survey of pediatric hematology oncology providers in the United States and Canada.

Pediatric Cancer Immunotherapy and Potential for Impact on Fertility: A Need for Evidence-Based Guidance

Fertility-Preserving Treatments and Patient- and Parental Satisfaction on Fertility Counseling in a Cohort of Newly Diagnosed Boys and Girls with Childhood Hodgkin Lymphoma

Fertility Preservation Strategies in Cancer Patients: A Comprehensive Review

Female fertility preservation in cancer patients

Healthcare professionals' views on discussing fertility preservation with young cancer patients: a mixed method systematic review of the literature